Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
Is a |
Product containing phenyltoloxamine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sederende antihistamin |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenyltoloxamine (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
Is a |
paracetamol + phenyltoloxamincitrat |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenyltoloxamine citrate |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Non-opioid analgesic (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paracetamol |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
Has manufactured dose form |
kapselformet tablet |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cardiovascular agent (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol 500 mg + phenyltoloxamincitrat 30 mg kapselformede tabletter |
Is a |
Product containing paracetamol in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|